Line 35: |
Line 35: |
| * [https://canadiantaskforce.ca/wp-content/uploads/2016/12/procedural-manual-en_2014_Archived.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1) | | * [https://canadiantaskforce.ca/wp-content/uploads/2016/12/procedural-manual-en_2014_Archived.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1) |
| * [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form] | | * [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form] |
− | * US FDA financial disclosure report – Executive Branch | + | * [https://www.uspto.gov/sites/default/files/documents/OGE450_June_2015.pdf US FDA financial disclosure report – Executive Branch] |
− | * US FDA financial disclosure report – Special Government Employees | + | * [https://www.fda.gov/media/70455/download US FDA financial disclosure report – Special Government Employees] |
− | * National Academies of Science Engineering and Medicine disclosure of interest form for general scientific and technical studies and assistance | + | * [https://www.nationalacademies.org/coi/bi-coi_form-3.pdf National Academies of Science Engineering and Medicine disclosure of interest form for general scientific and technical studies and assistance] |
− | * National Academies of Science Engineering and Medicine disclosure of interest form for studies involving program reviews and evaluations | + | * [https://www.nationalacademies.org/coi/bi-coi_form-2.pdf National Academies of Science Engineering and Medicine disclosure of interest form for studies involving program reviews and evaluations] |
− | * National Academies of Science Engineering and Medicine disclosure of interest form for studies related to government regulation | + | * [https://www.nationalacademies.org/coi/bi-coi_form-1.pdf National Academies of Science Engineering and Medicine disclosure of interest form for studies related to government regulation] |
| * National immunization technical advisory groups (NITAGs) | | * National immunization technical advisory groups (NITAGs) |
− | ** Initial COI declaration form | + | ** [http://www.nitag-resource.org/uploads/media/default/0001/04/e80de42a64ee6f017cc42996b34a0cbb6e056ff0.pdf Initial COI declaration form] |
− | ** COI annual update form | + | ** [http://www.nitag-resource.org/uploads/media/default/0001/04/e80de42a64ee6f017cc42996b34a0cbb6e056ff0.pdf COI annual update form] |
− | ** COI declaration prior to a meeting | + | ** [http://www.nitag-resource.org/uploads/media/default/0001/04/e80de42a64ee6f017cc42996b34a0cbb6e056ff0.pdf COI declaration prior to a meeting] |
| | | |
− | * National Institute for Health and Care Excellence (UK) disclosure of interest form for advisory committees | + | * [https://www.nice.org.uk/Media/Default/About/Who-we-are/Policies-and-procedures/declaration-form.docx National Institute for Health and Care Excellence (UK) disclosure of interest form for advisory committees] |
− | * National Institute of Health and Care Excellence (UK) disclosure of interest form for board members and employees | + | * [https://www.nice.org.uk/Media/Default/About/Who-we-are/Policies-and-procedures/declaring-and-managing-interests-board-and-employees.pdf National Institute of Health and Care Excellence (UK) disclosure of interest form for board members and employees] |
− | * Scottish Intercollegiate Guideline Network (SIGN) disclosure of interest form for completion by individuals, carers, voluntary organisations and members of the public | + | * [https://www.sign.ac.uk/assets/delirium_pat_doi_form.pdf Scottish Intercollegiate Guideline Network (SIGN) disclosure of interest form for completion by individuals, carers, voluntary organisations and members of the public] |
− | * United States Preventive Services Task Force (USPSTF) disclosure of interest form | + | * [https://www.uspreventiveservicestaskforce.org/Page/Name/appendix-ii-uspstf-conflict-of-interest-disclosure-form United States Preventive Services Task Force (USPSTF) disclosure of interest form] |
| + | |
| + | === Examples of published summaries of disclosures === |
| + | * Australian Technical Advisory Group on Immunisation disclosure summary |
| + | * Haute Authorité de Santé (France) examples of public disclosures of experts |
| + | |
| + | === Examples of scales for assessing the significance of COI === |
| + | * American Thoracic Society method for evaluating significance of COI |
| + | * World Health Organization criteria for assessing the severity of a conflict of interest (see p. 78) |
| + | * USPSTF COI significance and management table |
| | | |
| === Examples of algorithms/process maps for COI management === | | === Examples of algorithms/process maps for COI management === |
− | * American Thoracic Society COI resolution procedure | + | * [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i14 American Thoracic Society COI resolution procedure] |
| * CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A) | | * CADTH pan-Canadian Oncology Drug Review COI management overview (Appendix A) |
| * European Medicines Agency COI management matrix | | * European Medicines Agency COI management matrix |
Line 57: |
Line 66: |
| * National Research Council Canada COI flowchart | | * National Research Council Canada COI flowchart |
| * National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A) | | * National Institute of Health and Care Excellence (UK) process for declaring interests (Appendix A) |
− |
| |
− | === Examples of published summaries of disclosures ===
| |
− | o Australian Technical Advisory Group on Immunisation disclosure summary
| |
− |
| |
− | o Haute Authorité de Santé (France) examples of public disclosures of experts
| |
− |
| |
− | === Examples of scales for assessing the significance of COI ===
| |
− | o American Thoracic Society method for evaluating significance of COI
| |
− |
| |
− | o World Health Organization criteria for assessing the severity of a conflict of interest (see p. 78)
| |
− |
| |
− | o USPSTF COI significance and management table
| |
| | | |
| === [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] === | | === [https://annals.org/aim/fullarticle/2450219/guidelines-international-network-principles-disclosure-interests-management-conflicts-guidelines GIN principles paper] === |